Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: Results from the NCRI AML trials Meeting Abstract
| Authors: | Hills, R. K.; Gale, R.; Linch, D. C.; Huntly, B. J. P.; Papaemmanuil, E.; Vyas, P.; Burnett, A. K.; Russell, N. H. |
| Abstract Title: | Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: Results from the NCRI AML trials |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837602042 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-116482 |
| Notes: | Meeting Abstract: 664 -- Source: Wos |
